Tuesday, December 07, 2021

NEWS

Cuban president highlights development of Covid-19 diagnostic kit

Cuban president highlights development of Covid-19 diagnostic kit

Havana, Jul 5 (Prensa Latina) President Miguel Diaz-Canel on Monday highlighted the development and production of a Cuban-made diagnostic system, named UMELISA SARS-CoV-2 antigen, which will be included in the Covid-19 health and detection protocols in this country.
Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on email

On his Twitter account, the president described the breakthrough as another achievement of Cuban science.

The first 644 kits of the Umelisa SARS-COV-2 antigen diagnostic kit will be soon delivered to the Medicines Marketing and Distribution Company (EMCOMED), after exhaustive effectiveness tests, Cubavision Internacional informed.

This diagnostic kit developed by the Immunoassay Center identifies the presence of the virus that causes Covid-19 in suspected asymptomatic patients in just four hours.

According to Irinia Valdivia, deputy director of Development and Production of the diagnostic kits at the scientific institution, 826 kits will be delivered by July 8, and more than 1,600 kits by July 15.

The Cuban Health system will have more than 705,000 of those diagnostic kits.

jg/iff/mem/evm/gdc

RELATED
ÚLTIMO MINUTO
name of Prensa Latina

| Text SMS to 8100 with content PL
Receive 4 mesages x 25 cup

© 2016-2021 Prensa Latina
Latin American News Agency

Radio – Publications  – Videos – News by the minute.
All Rigts Reserved.

St. E No 454 , Vedado,  Habana, Cuba.
Phones: (+53) 7 838 3496, (+53) 7 838 3497, (+53) 7 838 3498, (+53) 7 838 3499
Prensa Latina © 2021 .

Web Site developed by IT Division  Prensa Latina.